{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:26:13Z","timestamp":1784075173356,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.thromres.2021.10.027","type":"journal-article","created":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T11:31:50Z","timestamp":1636198310000},"page":"129-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["COVID-19 adenovirus vaccine triggers antibodies against PF4 complexes to activate complement and platelets"],"prefix":"10.1016","volume":"208","author":[{"given":"Hanna H.","family":"Pitk\u00e4nen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annukka","family":"Jouppila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuukka","family":"Helin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinaya","family":"Dulipati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Kotimaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seppo","family":"Meri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Kantele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinja","family":"Jalkanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilkka","family":"Julkunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riitta","family":"Lassila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2021.10.027_bb0005","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2021.10.027_bb0010","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2021.10.027_bb0015","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2021.10.027_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12529","article-title":"Vaccine-induced immune thrombocytopenia and thrombosis (VITT)","volume":"5","author":"Makris","year":"2021","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.10.027_bb0025","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/jth.13813","article-title":"Autoimmune heparin-induced thrombocytopenia","volume":"15","author":"Greinacher","year":"2017","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.10.027_bb0030","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.150.3.633","article-title":"Human complement in thrombin-mediated platelet function: uptake of the c5b\u20139 complex","volume":"150","author":"Polley","year":"1979","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.thromres.2021.10.027_bb0035","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1111\/j.1538-7836.2006.02065.x","article-title":"Blood platelets activate the classical pathway of human complement","volume":"4","author":"Peerschke","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.10.027_bb0040","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.molimm.2010.05.009","article-title":"Complement activation on platelets: implications for vascular inflammation and thrombosis","volume":"47","author":"Peerschke","year":"2010","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.thromres.2021.10.027_bb0050","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00447-19","article-title":"Serological array-in-well multiplex assay reveals a high rate of respiratory virus infections and reinfections in young children","volume":"4","author":"Kazakova","year":"2019","journal-title":"MSphere"},{"key":"10.1016\/j.thromres.2021.10.027_bb0055","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0021-9673(01)85015-9","article-title":"Purification of adenovirus hexon protein by high-performance liquid chromatography","volume":"397","author":"Waris","year":"1987","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.thromres.2021.10.027_bb0060","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/infdis\/jiab222","article-title":"A combination of N and S antigens with IgA and IgG measurement strengthens the accuracy of SARS-CoV-2 serodiagnostics","volume":"224","author":"Jalkanen","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.thromres.2021.10.027_bb0065","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/01.ATV.21.4.628","article-title":"Procoagulant activity on platelets adhered to collagen or plasma clot","volume":"21","author":"Ilveskero","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2021.10.027_bb0070","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1161\/01.ATV.17.12.3578","article-title":"Native macromolecular heparin proteoglycans exocytosed from stimulated rat serosal mast cells strongly inhibit platelet-collagen interactions","volume":"17","author":"Lassila","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2021.10.027_bb0075","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ejim.2013.05.009","article-title":"Complement activation in diseases presenting with thrombotic microangiopathy","volume":"24","author":"Meri","year":"2013","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.thromres.2021.10.027_bb0080","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41423-020-0388-9","article-title":"Physiology of gangliosides and the role of antiganglioside antibodies in human diseases","volume":"17","author":"Cutillo","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.thromres.2021.10.027_bb0085","series-title":"Methods Mol. Biol","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/978-1-4939-8949-2_15","article-title":"Anti-factor H autoantibodies assay by ELISA","author":"S\u00e9nant","year":"2019"},{"key":"10.1016\/j.thromres.2021.10.027_bb0090","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2020009487","article-title":"Complement mediates binding and procoagulant effects of ultra-large HIT immune complexes","author":"Khandelwal","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2021.10.027_bb0095","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1182\/blood-2015-11-680009","article-title":"Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome","volume":"127","author":"Hyv\u00e4rinen","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2021.10.027_bb0100","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3389\/fimmu.2014.00649","article-title":"Platelets and infection - an emerging role of platelets in viral infection","volume":"5","author":"Assinger","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.thromres.2021.10.027_bb0105","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1538-7836.2004.00558.x","article-title":"Fibrin polymerization is crucial for thrombin generation in platelet-rich plasma in a VWF-GPlb-dependent process, defective in Bernard-soulier syndrome","volume":"2","author":"B\u00e9guin","year":"2004","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.10.027_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12551","article-title":"Respective roles of glycoprotein VI and Fc\u03b3RIIA in the regulation of \u03b1IIb\u03b23-mediated platelet activation to fibrinogen, thrombus buildup, and stability","volume":"5","author":"Ahmed","year":"2021","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.10.027_bb0115","doi-asserted-by":"crossref","DOI":"10.1177\/1076029620977702","article-title":"Rationale for the role of heparin and related GAG antithrombotics in COVID-19 infection","volume":"27","author":"Magnani","year":"2021","journal-title":"Clin. Appl. Thromb."},{"key":"10.1016\/j.thromres.2021.10.027_bb0120","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00281-011-0286-4","article-title":"Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum","volume":"34","author":"Vieira-De-Abreu","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.thromres.2021.10.027_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12959-021-00311-9","article-title":"Thrombosis in COVID-19 infection: role of platelet activation-mediated immunity","volume":"19","author":"Fard","year":"2021","journal-title":"Thromb. J."},{"key":"10.1016\/j.thromres.2021.10.027_bb0130","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3109\/09537104.2012.703792","article-title":"Platelet-adenovirus vs. Inert particles interaction: effect on aggregation and the role of platelet membrane receptors","volume":"24","author":"Gupalo","year":"2013","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2021.10.027_bb0135","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1074\/jbc.M606650200","article-title":"Platelet factor 4 (CXCL4) seals blood clots by altering the structure of fibrin","volume":"282","author":"Amelot","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.thromres.2021.10.027_bb0140","doi-asserted-by":"crossref","DOI":"10.1007\/s11239-021-02505-4","article-title":"Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis","author":"Marchandot","year":"2021","journal-title":"J. Thromb. Thrombolysis"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384821005004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384821005004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:47:13Z","timestamp":1758736033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384821005004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":27,"alternative-id":["S0049384821005004"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2021.10.027","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 adenovirus vaccine triggers antibodies against PF4 complexes to activate complement and platelets","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2021.10.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}